Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2007 Dec;14(12):3283-4.
doi: 10.1245/s10434-007-9507-4. Epub 2007 Sep 25.

More answers about prophylactic mastectomy

William C Wood
Editorial

More answers about prophylactic mastectomy

William C Wood. Ann Surg Oncol. 2007 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Heemskerk-Gerritsen, Brekelmans, Menke-Pluijmers, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann Surg Oncol 2007; 14: doi:10.1245/s10434-007-9449-x [Online May 31, 2007] - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1200/JCO.2004.00.4960', 'is_inner': False, 'url': 'https://doi.org/10.1200/jco.2004.00.4960'}, {'type': 'PubMed', 'value': '16293877', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16293877/'}]}
    2. Kuhl C, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk of breast cancer. J Clin Oncol 2005; 23:8469–8476 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1200/JCO.2004.00.7138', 'is_inner': False, 'url': 'https://doi.org/10.1200/jco.2004.00.7138'}, {'type': 'PubMed', 'value': '16234515', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16234515/'}]}
    2. Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case control study. J Clin Oncol 2005; 23:7491–7496 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/ijc.21536', 'is_inner': False, 'url': 'https://doi.org/10.1002/ijc.21536'}, {'type': 'PubMed', 'value': '16331614', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16331614/'}]}
    2. Gronwald J, Tung N, Foulkes WD, et al. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 2006; 118:2281–2284 - PubMed